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ÖZET
Amaç: Geli mi  ülkelerdeki diyetlerde fruktozun tüketilme 
sıklığı son yıllarda giderek artmaktadır. Artan fruktoz tüke 
timi insülin rezistansı olu turarak endotel disfonksiyonuna 
yol açabilir. İnsülin rezistansı, sendrom X, polikistik over 
sendromu, tip 2 diabet gibi birçok metabolik bozukluğun 
patogenezinde altta yatan etkendir. Çalı mamızın amacı, 
artmı  fruktoz tüketiminin, glukoz, insülin düzeylerine ve 
ayrıca metabolizmada kritik öneme sahip olan karaciğer 
dokusundaki endotel fonksiyonlarına olan etkilerini, nitrik 
oksit (NO) ve endothelin–1 (ET–1) ölçerek değerlendir 
mektir.
Gereç  ve  yöntem:  Çalı mamızda  20  erkek  sıçan  iki 
gruba ayrıldı. Çalı ma grubu (grup 1, n=10) fruktozdan 
zenginle tirilmi  izokalorik diyet ile (içeriği: %18.3 protein, 
%60.3 fruktoz ve %5.2 yağ), kontrol grubu ise (grup 2, 
n=10) puriﬁ  ye normal besin ile 2 hafta süresince beslendi. 
Beslenme periyodu sonrası kan ve hepatik doku örnekle 
ri alınarak glukoz, insulin, NO ve ET–1 düzeyleri analiz 
edildi.
Bulgular: Fruktozdan zengin beslenen sıçanlarda artmı  
açlık glukozu, insülin düzeyleri ve bozulmu  glukoz tole 
ransı izlendi. Grup 1 karaciğer dokularında ise yüksek NO 
ve dü ük ET–1 düzeyleri saptandı.
Sonuç: Artmı   fruktoz  tüketimi  glukoz  toleransını  boz 
makta ve insülin rezistansı olu turmaktadır. İnsülin rezis 
tansı karaciğer dokusunda endotel disfonksiyonuna yol 
açabilir.
Anahtar kelimeler: Fruktoz tüketimi, endotel disfonksiyo 
nu, nitrik oksit, endotelin–1, karaciğer.
ABSTRACT
Objectives: Dietary high fructose consumption which is 
closely associated with endothelial dysfunction via insulin 
resistance has recently increased in developed countries. 
Insulin resistance has a promoter effect on many meta 
bolic disorders such as syndrome X, polycystic ovary syn 
drome, Type 2 diabetes mellitus etc. Our aim in this study 
is to understand the impact of increased fructose intake 
on metabolisms of glucose, insulin and endothelial dys 
function by measuring nitric oxide (NO) and endothelin 1 
(ET 1) levels in hepatic tissue which is crucial in fructose 
metabolism.
Materials and Methods: We designed an animal study 
to understand increased fructose intake on hepatic en 
dothelium. Twenty  adult  male  albino  rats  were  divided 
into two groups; the study group (group 1, n=10) received 
isocaloric fructose enriched diet (fructose fed rats, con 
taining 18.3% protein, 60.3% fructose and 5.2% fat) while 
the control group received puriﬁ  ed regular chow (group 2, 
n=10) for 2 weeks. After feeding period, blood and hepatic 
tissue samples were collected and glucose, insulin, NO 
and ET 1 levels were analysed.
Results: We found increased fasting glucose and insulin 
levels and impaired glucose tolerance in fructose fed rats. 
Higher NO and lower ET–1 levels were also detected in 
hepatic tissue samples of the group 1.
Conclusion: Increased fructose consumption has delete 
rious effects on glucose tolerance, insulin resistance and 
may cause to endothelial dysfunction.
Key words: Fructose consumption, endothelial dysfunc 
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INTRODUCTION
More than 50% of energy must be provided from 
carbohydrates in adults on regular diet. Fructose is 
typically consumed as sucrose (table sugar), a di 
saccharide composed of equal parts of fructose and 
glucose, or as a component of high fructose corn 
syrup (HFCS, which is used to sweeten most cola 
drinks). High fructose corn syrup is a source of su 
crose and the overconsumption of HFCS is related 
to obesity .1 Varying concentrations of free fructose 
and free glucose are used to obtain HFCS. Accord 
ing to US Department of Agriculture data, inclusion 
of fructose ratio in HFCS varies between 42 55%. 2
Fructose  is  sweeter  than  glucose  (over  than 
2 fold) and it is transformed into lipids in the fast 
est pathway among all carbohydrates and therefore 
blamed for serious atherogenic effect. Fructose does 
not have insulin releasing effect and does not need 
insulin for its metabolism. An increase in fructose 
consumption over the past 10–20 years has been 
linked with a rise in the prevalence of obesity and 
metabolic  disorders.  3 4  Consumption  of  a  high 
fructose diet promotes development of three of the 
pathological characteristics associated with meta 
bolic  syndrome:  visceral  adiposity,  dyslipidemia, 
and insulin resistance.5 Insulin resistance is not only 
an early and major feature in development of non 
insulin dependent diabetes mellitus (NIDDM), but 
also associated with hyperlipidemia, hypertension, 
obesity, enhanced oxidative stress, endothelial dys 
function and cardiovascular disease, the so called 
‘insulin resistance  syndrome  (syndrome  X,  meta 
bolic syndrome).6,7 Metabolic syndrome is closely 
associated with endothelial dysfunction. Although 
endothelial  dysfunction  occurs  in  many  different 
disease processes,  oxidative  stress  can  be  identi 
ﬁ  ed as a common denominator. Nitric oxide (NO), 
superoxide radical (O2
–·), hydroxyl radical (·OH), 
hydrogene  peroxidase  (H2O2),  and  peroxynitrite 
(ONOO–·) are produced in the vascular bed under 
both normal and stress conditions such as inﬂ  am-
mation or injury8. When NO and O2
–· are produced 
in close vicinity, they interact to form ONOO–·. Al-
though neither NO nor superoxide is a strong oxi-
dant, peroxynitrite is a potent and versatile oxidant 
that can attack a wide range of biological targets. 9 
Reduced bioavailability of NO, an alteration in the 
production of  prostanoids,  including  prostacyclin, 
thromboxane A2, an impairment of endothelium-de-
pendent hyperpolarization, as well as an increased 
release of endothelin–1, can individually or in com-
bination contribute to endothelial dysfunction.8
Our aim in this study is to understand the im-
pact of increased fructose intake on metabolisms 
of glucose, insulin and endothelial dysfunction by 
measuring NO and endothelin–1 levels in hepatic 
tissue which is crucial in fructose metabolism.
MATERIALS AND METHODS
The study was approved by the Experimental Ani-
mal Ethics Committee of the Celal Bayar Univer-
sity Hospital (2005/3). After 1-week acclimatiza-
tion period, twenty adult male albino rats with an 
average weight of 205±24 grams were randomly 
divided into two groups. The study group (group 
1, n=10) received isocaloric fructose enriched diet 
(fructose-fed rats, containing 18.3% protein, 60.3% 
fructose and 5.2 % fat) while the control group re-
ceived puriﬁ  ed regular chow (group 2, n=10) for 2 
weeks.16 After at least 10 hours fasting period, blood 
was withdrawn from tail veins to measure fasting 
glucose and insulin levels. Then the rats were given 
30% glucose at 1,7 mg/kg dose, and 30 minutes lat-
er blood samples were obtained to measure glucose 
and insulin levels. After collecting blood samples, 
rats  were  sacriﬁ  ced  and  hepatectomy  was  per-
formed. Hepatic tissues were washed with cold sa-
line solution, placed into clean glass tubes, labeled 
and stored in a deep freeze at -70°C until the day of 
measurement.
Plasma glucose levels were detected by photo-
metric method using an automatic analyser (Beck-
man Coulter DxC 800), plasma insulin levels were 
measured by RIA method using a commercial kit 
(DSL–1600).
Hepatic  tissues  were  homogenised  at  16000 
rpm in four volumes of ice-cold Tris-HCl buffer 
(50 mM, pH 7.4) using a homogeniser (for 2 min at 
5000 rpm). The homogenate was then centrifuged at 
5000 g for 60 min to remove debris. Clear upper su-
pernatant ﬂ  uid was taken and NO and endothelin–1 
levels were carried out in this stage. Protein assays 
were made by the method of Lowry.
Since plasma nitrite (NO2
–) and nitrate (NO3
–) 
levels can be used to estimate NO production, we 
measured  the  concentrations  of  these  stable  NO 
oxidative metabolites. Determination of NO2
– and A. Var et al. Endothelial dysfunction and NO/Endothelin-1 levels 195
Dicle Tıp Derg / Dicle Med J Cilt / Vol 37, No 3, 193-198
NO3
– was based on the Griess reaction, in which a 
cromophore with a strong absorbance at 545 nm 
is formed by reaction of NO2
– with a mixture of 
naphthylethylenediamine and sulfanilamide. After 
samples were deproteinized with Somogyi reagent, 
an aliquot of the sample was mixed with fresh re 
agent. After 40 min incubation time the absorbance 
was measured in a spectrophotometer (Shimadzu 
UV 1201,  Japan)  to  give  the  NO2
– concentration. 
A second aliquot was treated with copper coated 
cadmium  granules  (Cd)  in  glycine  buffer  at  pH 
9.7 (2.5–3 g Cd granules for a 4 ml reaction mix 
ture) to reduce NO3
– to NO2
–. The concentration of 
NO2
– in this aliquot thus gave the total NO3
– plus 
NO2
–, ﬁ  nally representing total NO concentration. 
A standard curve was established with a set of serial 
dilutions (100–5 mmol/L) of NaNO2. The resulting 
equation was then used to calculate the unknown 
sample concentrations.
Endothelin–1 levels were detected by enzyme-
linked immunosorbent assay (ELISA) method using 
a commercial kit from Cayman Chemical Company 
(Cat. no: 583151) and were carried out in duplicate; 
the mean of the two measurements gave the ﬁ  nal 
result.
Statistical  Package  for  the  Social  Sciences 
(SPSS)  for  Windows,  Version  10.0  was  used  to 
statistical analysis of data. Mean values were ex-
pressed as x ± SD. Fort the differences between 
groups, nonparametric test; Kruskal–Wallis analy-
sis of variance (Mann–Whitney test as a post hoc 
test) were applied. A p value of less than 0.05 was 
accepted as statistically signiﬁ  cant.
RESULTS
After 2 weeks of diet, fructose fed rats (group 1) 
had hyperinsulinemia and exaggerated response to 
glucose overload (Table 1). Plasma fasting glucose 
and insulin levels were signiﬁ  cantly higher in group 
1 at both 0’ and 30’ (p=0.001, 0.02, 0.004 and 0.008 
respectively). Mean endothelin–1 and NO levels in 
hepatic tissue are seen in Table 1. We found signiﬁ  -
cantly higher NO (p=0.04) and lower endothelin–1 
levels (p=0.028) in group 1.
Table 1. Plasma glucose and insulin levels (x ± SD) at 0’ and after oral glucose loading (30’) and liver tissue NO and 
ET 1 levels in Group 1 and Group 2.
Time Group 1 (n=10) Group 2 (n=10) P
Glucose (mg/dL)
0. min 86.87±12.33* 50.00±6.63 0.001
30. min 120.25±7.06* 109.66±9.93 0.020
Insulin ( IU/mL)
0. min 35.10±6.92* 19.65±4.31 0.004
30. min 136.32±12.27* 87.90±9.77 0.008
NO ( mol/g tissue protein) 1.93 ± 1.03* 0.99 ± 0.31 0.04
ET 1 (pg/g tissue protein) 1.78 ± 0.40* 2.43 ± 0.55 0.028
DISCUSSION
Insulin resistance is usually characterized by higher 
fasting and post-glucose loading insulin levels, and 
a decreased responsiveness of tissue to the insulin 
driven  clearance  of  this  glucose  from  the  blood-
stream. It seems to be a common feature and a pos-
sible contributing factor to several frequent health 
problems, including Type 2 diabetes mellitus, poly-
cystic  ovary  syndrome,  dyslipidemia,  hyperten-
sion,  cardiovascular  disease,  sleep  apnea,  certain 
hormone-sensitive cancers and obesity.10 According 
to results of Steinberg et al.11, endothelium depen-
dent vasodilatation is reduced by 30-40% in obese 
humans compared to lean control group and they 
suggested that these patients are subject to endothe-
lial dysfunction which may be related to insulin re-
sistance.
Recent studies have shown that a high intake 
of reﬁ  ned carbohydrates may contribute to the risk 
of developing insulin resistance. In animal models, 
diets high in fructose have speciﬁ  cally been con-A. Var et al. Endothelial dysfunction and NO/Endothelin-1 levels 196
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tribute to a metabolic disturbance leading to insulin 
resistance.12  Unfortunately,  fructose  consumption 
rate has increased year after year in humans. Un 
til recently, humans consumed fructose amounting 
to 16–20 grams per day, largely from fresh fruits. 
Westernization of diets has resulted in signiﬁ  cant 
increases in added fructose, leading to typical daily 
consumptions amounting to 85–100 grams of fruc-
tose per day. Indeed, one out of every four children 
in the United States consumes above the recom-
mended 25% of total energy intake from sweeten-
ers. Exposure of the liver to such large quantities 
of fructose leads to rapid stimulation of lipogenesis 
and triglyceride (TG) accumulation, which in turn 
contributes to reduced insulin sensitivity and hepat-
ic insulin resistance/glucose intolerance.13
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Figure 1. The relationship between fructose metabolism and insulin resistanceA. Var et al. Endothelial dysfunction and NO/Endothelin-1 levels 197
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The relationship between fructose metabolism 
and insulin resistance in hepatic tissue is summa 
rized in Figure 1 (reviewed 13,14,15 ).
Many studies have shown that plasma TGs in 
creased signiﬁ  cantly in fructose fed rats whereas 
plasma glucose and insulin levels were controver-
sial from controls.16 In this study, we observed to 
glucose  and  insulin  levels  in  fasting  plasma  and 
responses  to  oral  glucose  load  were  signiﬁ  cantly 
greater in fructose-fed than in control rats. Increased 
TG levels can be harmful on liver cells. Accord-
ing to Porikos 17 study on healthy non-obese males 
who consumed a diet containing 20–35 percent of 
calories as sucrose, 3 of 11 participants (27%) de-
veloped markedly increased levels of alanine ami-
notransferase  (4.33-9.22  times  the  upper  limit  of 
normal) and moderate increases in aspartate amin-
otransferase (1.04-3.64 times the upper limit of nor-
mal), changes suggestive of liver injury. Additional 
evidence that fructose can cause liver damage is that 
intravenous administration of fructose (250 mg/kg 
of body weight over ﬁ  ve minutes) to healthy volun-
teers resulted in 75% reduction in the hepatic con-
centration of adenosine triphosphate (ATP) within 
10 minutes. Sixty minutes after fructose administra-
tion, the ATP concentration still decreased by about 
40% compared with baseline.18 The possible reason 
for this untoward result is overwhelming the capac-
ity of aldolase B in fructose metabolism pathway 
due to ingestion of large amounts of fructose. In 
fact, hereditary fructose intolerance (absence of al-
dolase B) leads to intracelluler trapping of fructose 
1-P, accumulation in liver cells and eventually ATP 
and inorganic phosphate levels decrease. Decreased 
availability  of  hepatic ATP  impairs  gluconeogen-
esis (causing hypoglycemia), and protein synthesis 
(causing a decrease in blood clotting factors and 
other essential proteins).
Fructose overload has been shown to increase 
oxidative  stress.  Delbosc19 et  al.,  found  that  high 
fructose feeding was also associated with an early 
(1-week) increase in reactive oxygen species (ROS) 
production and they have suggested that the produc-
tion of ROS can be a key-event in the initiation and 
development  of  cardiovascular  complications  as-
sociated with insulin resistance. Some authors also 
have reported that high fructose diet (HFD) in rats 
led to insulin resistance and a defect in the free radi-
cal defence system.20-21 These results indicate that 
consumption of HFD (also sucrose) negatively af-
fects the balance of free radical production and anti-
oxidant defence, leading to increased lipid suscepti-
bility to peroxidation. Fructose overload dependent 
insulin resistance and increased free radicals may 
result in unfavourable effects on endothelial cells. 
We found increased NO and decreased endothelin–1 
levels in hepatic tissues of fructose overload rats. 
High fructose diet may responsible that increased 
NO levels in the hepatic tissue and also some other 
tissues, such as kidney, heart, aorta etc. Cosenzi et 
al.22 have demonstrated increased urinary NO excre-
tion in high fructose fed rats and suggested a role for 
NO in the pathogenesis of the early renal changes 
induced by HFD. In another study on female rats, 
decreased heart superoxide dismutase activity and 
3-fold increase in plasma NO concentration were re-
ported in fructose fed group compared with starch-
fed females.23 In this study, they suggested that es-
trogen protected female rats against the pro-oxidant 
effect of high sucrose diet. Furthermore, while se-
rum nitrite/nitrate (NO) levels did not signiﬁ  cantly 
differ between the fructose-fed and control groups, 
NO levels in the aorta signiﬁ  cantly increased. Our 
study indicates that plasma and tissue NO levels 
may differ. ET–1 mRNA expression in the aorta in-
creased 195% in fructose-fed rats and the authors 
suggested  that  increased  expression  of  vascular 
ET-1 might be causally related to the development 
of hypertension in fructose-fed rats.24 Catena et al.16 
have found increased systolic blood pressure (BP) 
in fructose fed rats (control, 151±4 mmHg; fruc-
tose-fed, 179±10 mmHg; p<0.05) and they suggest, 
fructose-enriched diets induces an increase in BP 
that is associated with insulin resistance. Decreased 
endothelin levels found in our study, may reply for 
increased BP in hepatic tissues. However, kept in 
mind that endothelin levels may differ at other tis-
sues especially aorta.
We consider that the changes in NO and en-
dothelin levels may contribute to amelioration of 
tissue endothel dysfunction by decreasing insulin 
resistance at the target tissue and also manage the 
BP. A recent study, gene therapy with pcDNA3.1-
human eNOS decreased fructose-induced hyperten-
sion and insulin resistance in rats.25 According to 
authors, eNOS gene therapy may be important in 
the treatment of hypertension and insulin resistance. 
However, increased NO levels may also help pre-
vent or delay the occurrence of atherogenic cardio-
vascular diseases associated with insulin-resistant A. Var et al. Endothelial dysfunction and NO/Endothelin-1 levels 198
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states. It should be kept in mind that increased free 
radicals, especially superoxide anion, may reduce 
NO bioavailability. Superoxide radicals cannot be 
dismuted  in  the  absence  of  Cu Zn  SOD  enzyme 
and these increased radicals can interact with NO 
to  form  peroxynitrite  radicals  eventually  leading 
to  aggravation  of  cellular  injury  via  membrane 
damage.20 21  However,  no  reduction  of  Mn SOD, 
GPx and catalase levels found by Busserolles et al. 
20 in fructose fed rats may protect probable mito 
chondrial damage.
In  conclusion,  increased  fructose  consump 
tion has beyond doubt deleterious effects such as 
impaired glucose tolerance, insulin resistance, hy 
perlipidemia, oxidative stress and endothelial dys 
function. Frequent fructose intake may induce en 
dothelial dysfunction leading to progressive hepatic 
injury. Increasing of NO levels may help to improve 
these deleterious effects. Keeping dietary fructose 
ratio in an optimum range and addition of some an 
tioxidant agents in the western diets may be effec 
tive in prevention of cellular damage.
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